Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
FATE THERAPEUTICS INC | Director | Stock Option (Right to Buy) | 40K | $109K | $2.73 | Jun 7, 2024 | Direct |
Omega Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 25K | Jun 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OMGA | Omega Therapeutics, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
FATE | FATE THERAPEUTICS INC | Jun 7, 2024 | 1 | $0 | 4 | Jun 11, 2024 | Director |
OMGA | Omega Therapeutics, Inc. | Jun 7, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
FATE | FATE THERAPEUTICS INC | Jun 6, 2023 | 1 | $0 | 4 | Jun 7, 2023 | Director |
FATE | FATE THERAPEUTICS INC | Jan 19, 2023 | 2 | $39K | 4 | Jan 20, 2023 | Director |
FATE | FATE THERAPEUTICS INC | Jan 11, 2023 | 2 | $698K | 4 | Jan 13, 2023 | Director |
FATE | FATE THERAPEUTICS INC | Jun 9, 2022 | 2 | $0 | 4 | Jun 13, 2022 | Director |
OMGA | Omega Therapeutics, Inc. | Jun 8, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
FATE | FATE THERAPEUTICS INC | Jun 3, 2022 | 1 | -$31.1K | 4 | Jun 6, 2022 | Director |
FATE | FATE THERAPEUTICS INC | Mar 10, 2022 | 4 | -$1.05M | 4 | Mar 11, 2022 | Director |
OMGA | Omega Therapeutics, Inc. | Jul 29, 2021 | 0 | $0 | 3 | Jul 29, 2021 | Director |
FATE | FATE THERAPEUTICS INC | Jun 2, 2021 | 2 | $0 | 4 | Jun 4, 2021 | Director |